Aker BioMarine ASA (OSL:AKBM)
Norway
· Delayed Price · Currency is NOK 98.40
+1.60 (1.65%)
Apr 29, 2026, 4:10 PM CET
Aker BioMarine ASA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 218.1 | 199 | 196.3 | 277.2 | 262.1 | Upgrade
|
| Revenue | 218.1 | 199 | 196.3 | 277.2 | 262.1 | Upgrade
|
| Revenue Growth (YoY) | 9.60% | 1.38% | -29.18% | 5.76% | -9.18% | Upgrade
|
| Cost of Revenue | 120.3 | 120.6 | 123.8 | 162.4 | 174 | Upgrade
|
| Gross Profit | 97.8 | 78.4 | 72.5 | 114.8 | 88.1 | Upgrade
|
| Selling, General & Admin | 69.1 | 68 | 66.4 | 86.5 | 84.3 | Upgrade
|
| Other Operating Expenses | -2 | -1 | 0.1 | -4.4 | -2.7 | Upgrade
|
| Operating Expenses | 85 | 82.4 | 82.8 | 98.5 | 95 | Upgrade
|
| Operating Income | 12.8 | -4 | -10.3 | 16.3 | -6.9 | Upgrade
|
| Interest Expense | -13.9 | -2.5 | -19.7 | -20.3 | -13.7 | Upgrade
|
| Interest & Investment Income | 1 | 3.6 | 1.5 | 0.6 | - | Upgrade
|
| Earnings From Equity Investments | -2.4 | - | -3 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 1.1 | -1 | -0.8 | 8.1 | 0.6 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.3 | -8.1 | - | -1.7 | -1.7 | Upgrade
|
| EBT Excluding Unusual Items | -2.7 | -12 | -32.3 | 3 | -21.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.4 | Upgrade
|
| Asset Writedown | -0.1 | -1.2 | - | - | -5.8 | Upgrade
|
| Other Unusual Items | - | - | - | 9.2 | 19.7 | Upgrade
|
| Pretax Income | -2.8 | -12.1 | -32.3 | 12.2 | -7.4 | Upgrade
|
| Income Tax Expense | - | -0.1 | - | 2.2 | 0.6 | Upgrade
|
| Earnings From Continuing Operations | -2.8 | -12 | -32.3 | 10 | -8 | Upgrade
|
| Earnings From Discontinued Operations | -20 | 194.6 | 23.3 | - | - | Upgrade
|
| Net Income | -22.8 | 182.6 | -9 | 10 | -8 | Upgrade
|
| Net Income to Common | -22.8 | 182.6 | -9 | 10 | -8 | Upgrade
|
| Shares Outstanding (Basic) | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Change (YoY) | 0.02% | 0.02% | 0.04% | 0.05% | 12.20% | Upgrade
|
| EPS (Basic) | -0.26 | 2.08 | -0.10 | 0.11 | -0.09 | Upgrade
|
| EPS (Diluted) | -0.26 | 2.08 | -0.10 | 0.11 | -0.09 | Upgrade
|
| Free Cash Flow | -2.1 | -5.2 | 1.5 | -25.4 | -76.1 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.06 | 0.02 | -0.29 | -0.87 | Upgrade
|
| Gross Margin | 44.84% | 39.40% | 36.93% | 41.41% | 33.61% | Upgrade
|
| Operating Margin | 5.87% | -2.01% | -5.25% | 5.88% | -2.63% | Upgrade
|
| Profit Margin | -10.45% | 91.76% | -4.58% | 3.61% | -3.05% | Upgrade
|
| Free Cash Flow Margin | -0.96% | -2.61% | 0.76% | -9.16% | -29.04% | Upgrade
|
| EBITDA | 34.3 | 37.1 | 10.4 | 61.1 | 38.5 | Upgrade
|
| EBITDA Margin | 15.73% | 18.64% | 5.30% | 22.04% | 14.69% | Upgrade
|
| D&A For EBITDA | 21.5 | 41.1 | 20.7 | 44.8 | 45.4 | Upgrade
|
| EBIT | 12.8 | -4 | -10.3 | 16.3 | -6.9 | Upgrade
|
| EBIT Margin | 5.87% | -2.01% | -5.25% | 5.88% | -2.63% | Upgrade
|
| Effective Tax Rate | - | - | - | 18.03% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.